Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

About this episode

Dr. Lajos Pusztai discusses the role of circulating tumor DNA assays in breast cancer management.

Dr Lajos Pusztai from Yale Cancer Center in New Haven, Connecticut, discusses recent developments with circulating tumor DNA assays in the management of breast cancer. CME information and select publications here .

People in this episode

Host: Dr. Neil Love

Guest: Dr Lajos Pusztai

Topics covered

• breast cancer
• circulating tumor DNA
• tumor-informed assays
• cancer management
• medical developments

Keywords

• breast cancer
• circulating tumor DNA
• assays
• cancer management
• Yale Cancer Center

Mentioned in this episode

Organizations: Yale Cancer Center

Places: New Haven, Connecticut

More episodes of Breast Cancer Update

• HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy · June 11, 2026 · 58 min
• Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper · June 2, 2026 · 23 min
• Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances · April 30, 2026 · 57 min
• HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making · April 16, 2026 · 1h 0m
• ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy · April 14, 2026 · 58 min
• Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan · April 7, 2026 · 28 min